Re: What a Battlefield This Has Become
First off, thank you for your contributions. You have been "accretive" to the sum of knowledge here. You have also provided substantive reasons for being skeptical of LGND, something that Tony has utterly failed to do.
However...
I don't have that report in my files, but here's one from Peter Ginsberg, Vector Securities, 5/30/95...... projected sales,
1998......
Come on, Richard, now who's being irrelevant? Using Vector to indict RS?? If you didn't have the RS report, you ought to have just let it be.
Furthermore...
projected sales,
1998...... LGD 1057, $44.6 million, LGD 1069, $26.3 million, IL-2, $4.6 million, and Photofrin, $7.7 million.
Well, to give you your due, this does underscore the folly of making sales projections for development stage biotechs, but the IL-2 projections were a big 3.82% of the total. Well, la-teee-da. If you don't have the RS report "in your files," just do the math. :-)
BTW, my Henry and Tony needling credentials are well established on this thread. Neither of them is a credible resource for evaluating this stock as an investment, although each comes through in his own way on occasion.
Lookng forward to your continuing input.
Pý |
